1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,140 | 0,180 | 13:04 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.11.25 | Sprint Bioscience Announces Sale Of TREX1 Program to Gilead Sciences | 670 | AFX News | FOSTER CITY (dpa-AFX) - Sprint Bioscience AB (SPRINT.ST) announced the sale of its TREX1 cancer program to Gilead Sciences. The deal includes an upfront payment of $14 million, as well as potential... ► Artikel lesen | |
| SPRINT BIOSCIENCE Aktie jetzt für 0€ handeln | |||||
| 02.04.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.04.2025 | 1.324 | Xetra Newsboard | Das Instrument 2NH ES0105043006 NATURHOUSE HEALTH EO-,05 EQUITY wird cum Kapitalmassnahme gehandelt am 02.04.2025 und ex Kapitalmassnahme am 03.04.2025 The instrument 2NH ES0105043006 NATURHOUSE HEALTH... ► Artikel lesen |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 15,510 | -3,21 % | Palatin Technologies, Inc.: Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update | Significant progress on multiple fronts - obesity pipeline advancing towards the clinic, out-licensing collaboration, strengthened balance sheet, and reinstatement... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 1,550 | -5,49 % | COSCIENS Biopharma Inc. Announces Leadership Change | TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on natural ingredients and pharmaceutical... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 68,80 | +0,15 % | Halozyme Therapeutics: Die bessere Evotec? | Halozyme Therapeutics ist den meisten Anlegern hierzulande vermutlich durch den Übernahmeversuch Evotecs vorletztes Jahr bekannt. Eine Akquisition zu 11 € je Aktie scheiterte jedoch, da die Deutschen... ► Artikel lesen | |
| ABCELLERA BIOLOGICS | 2,636 | -1,24 % | AbCellera Biologics Inc. - 8-K, Current Report | ||
| GLOW LIFETECH | 0,025 | -12,28 % | Glow Lifetech Corp.: Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy | Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the expansion of its MOD and .decimal... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 255,00 | 0,00 % | Biodesix, Inc.: Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital PCR High Complexity Assays | LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which... ► Artikel lesen | |
| AVID BIOSERVICES | - | - | Avid Bioservices Appoints Rich McAvoy as Chief Business Officer | Seasoned business and finance leader brings disciplined growth mindset to support Avid's next phase of expansion and client executionTUSTIN, Calif., Jan. 15, 2026 /PRNewswire/ -- Avid Bioservices... ► Artikel lesen | |
| BIOLINERX | 2,225 | -5,32 % | BioLineRx Ltd.: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update | - Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 3,620 | -10,84 % | Minerva Neurosciences, Inc. - 8-K, Current Report | ||
| WHITEHAWK THERAPEUTICS | 2,220 | -5,93 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer | Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic
MORRISTOWN, N.J., Dec. 1, 2025 /PRNewswire/ -- Whitehawk... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 0,080 | -100,00 % | Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics | Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: APLT; "Applied"), a clinical-stage biopharmaceutical... ► Artikel lesen | |
| OVID THERAPEUTICS | 1,290 | -3,73 % | Ovid Therapeutics Inc.: Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer | NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need,... ► Artikel lesen | |
| GEOVAX LABS | 2,700 | +4,65 % | EQS-News: GeoVax Labs, Inc.: GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement | GeoVax, Inc. / Key word(s): Financial
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
08.01.2026 / 15:03 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| COCRYSTAL | 0,770 | -6,67 % | Cocrystal Pharma, Inc.: Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus | Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral gastroenteritis... ► Artikel lesen |
SPRINT BIOSCIENCE AB gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -5,13 % bei einem Aktienkurs von 0,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPRINT BIOSCIENCE AB finden Sie auf Wallstreet Online.